opioid

News

Beckley Canopy Therapeutics raises £7.4m for cannabis R&D

Oxford-based biopharma Beckley Canopy Therapeutics has raised £7.4 million to develop a range of cannabis-based products for the treatment of pain and to help tackle

News

Pain Therapeutics' opioid drug fails to gain FDA approval

The US regulator has rejected Pain Therapeutics' abuse-deterrent opioid painkiller drug, Remoxy, for the fourth time.

News

FDA refuses to approve Insys opioid painkiller

The US regulators have rejected Insys Therapeutics' opioid-based painkiller because of concerns about its safety.

Partner Content

Pain Therapeutics conference is taking place in London next ...

SMi Group reports: To reserve last available seats at the Pain Therapeutics Conference, head on to the event website http://www.pain-therap

News

FDA approves Indivior's long-lasting opioid withdrawal thera...

Monthly injection will help addicts manage withdrawal symptoms

News

FDA delays decision on abuse deterrence data on Endo painkil...

Data could be used to fend off generic competition.

Beckley Canopy Therapeutics raises £7.4m for cannabis R&D

Pain Therapeutics' opioid drug fails to gain FDA approval

FDA refuses to approve Insys opioid painkiller

Pain Therapeutics conference is taking place in London next ...

FDA approves Indivior's long-lasting opioid withdrawal thera...

FDA delays decision on abuse deterrence data on Endo painkil...

LSX2026: Addressing adult eye cancer, with Roi Raz

Using AI-driven synthetic personas to take your insights fur...

opioid

Editor's Picks